Many Older People Embrace Vaccines. Research Is Proving Them Right.
Newer formulations are even more effective at preventing illnesses that commonly afflict seniors — perhaps even dementia.
Health Industry
341 - 360 of 3,977 Results
-
Supreme Court Upholds Bans on Gender-Affirming Care
Episode 402The Supreme Court this week said Tennessee may continue to enforce its law banning most types of gender-affirming care for minors. The ruling is likely to greenlight similar laws in two dozen states. And the Senate is preparing to vote on a budget reconciliation bill that includes even deeper Medicaid cuts than the House version. Victoria Knight of Axios, Alice Miranda Ollstein of Politico, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these stories and more.
-
Nurse Practitioners Critical in Treating Older Adults as Ranks of Geriatricians Shrink
The number of nurse practitioners specializing in geriatrics has more than tripled since 2010.
By Jariel Arvin -
‘Not Accountable to Anyone’: As Insurers Issue Denials, Some Patients Run Out of Options
Health insurers issue millions of prior authorization denials every year, leaving many patients stuck in a convoluted appeals process, with little hope of meaningful policy change ahead. For doctors, these denials are frustrating and time-consuming. For patients, they can be devastating.
-
NIH Workers Risk Retaliation by Openly Protesting Trump Policies
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
-
CDC Staffing Upheaval Disrupts HIV Projects and Wastes Money, Researchers Say
Researchers laid off in April were putting the finishing touches on in-depth HIV surveys that guide treatment and prevention. Some staff have been reinstated, but data remains in limbo.
By Amy Maxmen RFK Jr. Upends Vaccine Policy, After Promising He Wouldn’t
Episode 401Health and Human Services Secretary Robert F. Kennedy Jr. this week did something he had promised not to do: He fired every member of the scientific advisory committee that recommends which vaccines should be given to whom. And he replaced them, in some cases, with vaccine skeptics. Meanwhile, hundreds of employees of the National Institutes of Health sent an open letter to the agency’s director, accusing the Trump administration of policies that “undermine the NIH mission.” Anna Edney of Bloomberg News, Sarah Karlin-Smith of the Pink Sheet, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine join KFF Health News’ Julie Rovner to discuss these stories and more.
-
Readers Endorse Doctor Migration and Shun ‘Elderspeak’
KFF Health News gives readers a chance to comment on a recent batch of stories.
-
Four Ways Trump’s ‘One Big Beautiful Bill’ Would Undermine Access to Obamacare
The combination of the House-passed spending and tax bill and the Trump administration’s regulatory action could change Affordable Care Act enrollment and the cost of insurance. The result, according to the Congressional Budget Office, is that millions of people may become uninsured.
-
As Federal Health Grants Shrink, Memory Cafes Help Dementia Patients and Their Caregivers
Memory cafes are small social gatherings for individuals with memory loss and their caregivers. The events are cheap to run and can offer measurable benefits. Memory loss experts say they may become an even more important tool in the face of federal cuts to health programs.
-
$20K Bonuses Among Latest Moves To Improve California’s Prison Mental Health System
After decades of unsuccessful efforts to improve California prison conditions, advocates and a federal judge are betting that bonuses and better work accommodations will attract and keep the mental health professionals needed to better treat prisoners.
By Don Thompson -
In Axing mRNA Contract, Trump Delivers Another Blow to US Biosecurity, Former Officials Say
The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health budgets, and withdraws funding for bird flu vaccines, health security experts said.
By Amy Maxmen -
Two Patients Faced Chemo. The One Who Survived Demanded a Test To See if It Was Safe.
Worried that President Donald Trump’s FDA might not act, a panel of cancer experts recommended that doctors consider testing before dosing patients with a commonly used but sometimes deadly cancer drug. It came too late for many patients.
By Arthur Allen -
Ballad Health’s Hospital Monopoly Underperformed. Then Tennessee Lowered the Bar.
Ballad Health, a state-sanctioned hospital monopoly in Tennessee and Virginia, can now be deemed a “clear and convincing” benefit to the public with performance that would earn a “D” on most grading scales, according to Tennessee state documents.
By Brett Kelman -
At Trump’s FDA, Anti-Regulatory Approach and Cost-Cutting Put Food Safety System at Risk
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
-
American Doctors Are Moving to Canada To Escape the Trump Administration
Canada has seen a surge of American doctors seeking to move north in the months since President Donald Trump returned to the White House.
By Brett Kelman -
Language Service Cutbacks Raise Fear of Medical Errors, Misdiagnoses, Deaths
Federal cuts are hurting community organizations in California that provide language assistance services to people who speak limited English. Despite President Trump’s executive order declaring English the national language, millions in the U.S. need help navigating the health system.
-
Call Centers Replaced Many Doctors’ Receptionists. Now, AI Is Coming for Call Centers.
Artificial intelligence products with lifelike voices are being marketed to schedule or cancel medical visits, refill prescriptions, and help triage patients. Soon, many patients might initiate contact with the health system by speaking not with a human but with AI.
By Darius Tahir -
Trump Won’t Force Medicaid To Cover GLP-1s for Obesity. A Few States Are Doing It Anyway.
Late last year, South Carolina Medicaid approved a class of medications known as GLP-1s to treat obesity, placing it among the few state programs covering these effective but expensive drugs. But access remains limited, even for patients covered by Medicaid, because of stringent prerequisites that must be satisfied before starting the drug.
-
This News Might Ruin Your Appetite — And Summer
Fresh studies expose a gap in the FDA’s assessments of foods: Widely used additives could damage the mix of bacteria in your gut, causing health problems.